The ecosystem at SBC enabled us to spin out not one but two companies, secure > £60m from global investors and attract the talent we need to progress our much needed therapies for chronic conditions.
Dr Mary Kerr, CEO of both NeRRe and KaNDy Therapeutics
The ecosystem at SBC enabled us to spin out not one but two companies, secure > £60m from global investors and attract the talent we need to progress our much needed therapies for chronic conditions.
Dr Mary Kerr, CEO of both NeRRe and KaNDy Therapeutics
Scientific support
The campus offers a truly comprehensive range of highly specialised facilities. The Community lab provides access to essential equipment and the Cytiva Technology lab to more specialist facilities.
The Cell and Gene Therapy Catapult manufacturing centre, through colaborators, helps to address the challenges faced by therapy developers.
Scientific support
The campus offers a truly comprehensive range of highly specialised facilities. The Community lab provides access to essential equipment and the Cytiva Technology lab to more specialist facilities.
The Cell and Gene Therapy Catapult manufacturing centre, through colaborators, helps to address the challenges faced by therapy developers.
